These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 31363735)

  • 1. Towards clinical utility of polygenic risk scores.
    Lambert SA; Abraham G; Inouye M
    Hum Mol Genet; 2019 Nov; 28(R2):R133-R142. PubMed ID: 31363735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.
    Mars N; Koskela JT; Ripatti P; Kiiskinen TTJ; Havulinna AS; Lindbohm JV; Ahola-Olli A; Kurki M; Karjalainen J; Palta P; ; Neale BM; Daly M; Salomaa V; Palotie A; Widén E; Ripatti S
    Nat Med; 2020 Apr; 26(4):549-557. PubMed ID: 32273609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes.
    Lu T; Forgetta V; Yu OHY; Mokry L; Gregory M; Thanassoulis G; Greenwood CMT; Richards JB
    Cardiovasc Diabetol; 2020 Jan; 19(1):12. PubMed ID: 32000781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating polygenic risk scores for clinical use by estimating the confidence bounds of risk prediction.
    Sun J; Wang Y; Folkersen L; Borné Y; Amlien I; Buil A; Orho-Melander M; Børglum AD; Hougaard DM; ; Melander O; Engström G; Werge T; Lage K
    Nat Commun; 2021 Sep; 12(1):5276. PubMed ID: 34489429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians.
    Wünnemann F; Sin Lo K; Langford-Avelar A; Busseuil D; Dubé MP; Tardif JC; Lettre G
    Circ Genom Precis Med; 2019 Jun; 12(6):e002481. PubMed ID: 31184202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the performance of European-derived cardiometabolic polygenic risk scores in South-Asians and their interplay with family history.
    Hassanin E; Maj C; Klinkhammer H; Krawitz P; May P; Bobbili DR
    BMC Med Genomics; 2023 Jul; 16(1):164. PubMed ID: 37438803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Bias in Polygenic Risk Prediction Models for Coronary Artery Disease.
    Gola D; Erdmann J; Läll K; Mägi R; Müller-Myhsok B; Schunkert H; König IR
    Circ Genom Precis Med; 2020 Dec; 13(6):e002932. PubMed ID: 33170024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition.
    Hughes E; Wagner S; Pruss D; Bernhisel R; Probst B; Abkevich V; Simmons T; Hullinger B; Judkins T; Rosenthal E; Roa B; Domchek SM; Eng C; Garber J; Gary M; Klemp J; Mukherjee S; Offit K; Olopade OI; Vijai J; Weitzel JN; Whitworth P; Yehia L; Gordon O; Pederson H; Kurian A; Slavin TP; Gutin A; Lanchbury JS
    JCO Precis Oncol; 2022 Nov; 6():e2200084. PubMed ID: 36331239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of coronary artery disease clinical risk factors by coronary artery disease polygenic risk score.
    Truong B; Ruan Y; Haidermota S; Patel A; Surakka I; Hornsby W; Koyama S; Lee SH; Natarajan P
    Med; 2024 May; 5(5):459-468.e3. PubMed ID: 38642556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
    Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
    Elife; 2022 Jul; 11():. PubMed ID: 35801699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer.
    Wu C; Zhu J; King A; Tong X; Lu Q; Park JY; Wang L; Gao G; Deng HW; Yang Y; Knudsen KE; Rebbeck TR; Long J; Zheng W; Pan W; Conti DV; Haiman CA; Wu L
    Cancer Commun (Lond); 2021 Dec; 41(12):1387-1397. PubMed ID: 34520132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer's Disease.
    Vlachakis D; Papakonstantinou E; Sagar R; Bacopoulou F; Exarchos T; Kourouthanassis P; Karyotis V; Vlamos P; Lyketsos C; Avramopoulos D; Mahairaki V
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic comparison of family history and polygenic risk across 24 common diseases.
    Mars N; Lindbohm JV; Della Briotta Parolo P; Widén E; Kaprio J; Palotie A; ; Ripatti S
    Am J Hum Genet; 2022 Dec; 109(12):2152-2162. PubMed ID: 36347255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic prediction via Bayesian regression and continuous shrinkage priors.
    Ge T; Chen CY; Ni Y; Feng YA; Smoller JW
    Nat Commun; 2019 Apr; 10(1):1776. PubMed ID: 30992449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygenic risk score in prostate cancer.
    Oh JJ; Hong SK
    Curr Opin Urol; 2022 Sep; 32(5):466-471. PubMed ID: 35855560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Implementation of Penalized Regression for Genetic Risk Prediction.
    Privé F; Aschard H; Blum MGB
    Genetics; 2019 May; 212(1):65-74. PubMed ID: 30808621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of polygenic risk scores to differentiate between type 1 and type 2 diabetes.
    Shoaib M; Ye Q; IglayReger H; Tan MH; Boehnke M; Burant CF; Soleimanpour SA; Gagliano Taliun SA
    Genet Epidemiol; 2023 Jun; 47(4):303-313. PubMed ID: 36821788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk scores in atrial fibrillation: Associations and clinical utility in disease prediction.
    Gibson JT; Rudd JHF
    Heart Rhythm; 2024 Jun; 21(6):913-918. PubMed ID: 38336192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research.
    Lopez-Pineda A; Vernekar M; Moreno-Grau S; Rojas-Muñoz A; Moatamed B; Lee MTM; Nava-Aguilar MA; Gonzalez-Arroyo G; Numakura K; Matsuda Y; Ioannidis A; Katsanis N; Takano T; Bustamante CD
    Hum Genomics; 2022 Sep; 16(1):37. PubMed ID: 36076307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying factors that affect polygenic risk score performance across diverse ancestries and age groups for body mass index.
    Hui D; Xiao B; Dikilitas O; Freimuth RR; Irvin MR; Jarvik GP; Kottyan L; Kullo I; Limdi NA; Liu C; Luo Y; Namjou B; Puckelwartz MJ; Schaid D; Tiwari H; Wei WQ; Verma S; Kim D; Ritchie MD
    Pac Symp Biocomput; 2023; 28():437-448. PubMed ID: 36540998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.